Galip Can Uyar: The Prognostic Value of LRF and Inflammatory Biomarkers in SCLC
Galip Can Uyar/LinkedIn

Galip Can Uyar: The Prognostic Value of LRF and Inflammatory Biomarkers in SCLC

Galip Can Uyar, Medical Doctor at Etlik City Hospital, shared a post on X about a paper he co-authored with colleagues, published in Clinical and Translational Oncology:

“Excited to share our new article in Clinical and Translational Oncology!

We highlight the prognostic value of PET/CT-derived liver-to-muscle FDG uptake ratio (LRF) and inflammatory biomarkers in small-cell lung cancer.

Elevated LRF reflects metabolic frailty and predicts poor outcomes.”

Title: Prognostic significance of liver-to-muscle FDG uptake ratio and ınflammatory biomarkers in small cell lung cancer

Authors: Kadriye Başkurt, Semra Demirtaş Şenlik, Galip Can Uyar, Enes Yeşilbaş, Ömür Berna Çakmak Öksüzoğlu, Osman Sütcüoğlu

You can read the Full Article in Clinical and Translational Oncology.

You can also read the first author’s post on OncoDaily.

Liver-to-Muscle FDG

More posts featuring Galip Can Uyar.